CELEX: 62018TA0380
Language: en
Date: 2019-11-07 00:00:00
Title: Case T-380/18: Judgment of the General Court of 7 November 2019 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS) (EU trade mark — Opposition proceedings — Application for the EU word mark INTAS — Earlier EU and national figurative trade marks including the word element ‘indas’ — Relative ground for refusal — Likelihood of confusion — Similarity of the signs and of the goods — Article 8(1)(b) of Regulation (EU) 2017/1001 — Proof of genuine use of the earlier marks — Article 47 of Regulation 2017/1001)

23.12.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 432/42
            
         
      Judgment of the General Court of 7 November 2019 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS)
      (Case T-380/18) (1)
      
      (EU trade mark - Opposition proceedings - Application for the EU word mark INTAS - Earlier EU and national figurative trade marks including the word element ‘indas’ - Relative ground for refusal - Likelihood of confusion - Similarity of the signs and of the goods - Article 8(1)(b) of Regulation (EU) 2017/1001 - Proof of genuine use of the earlier marks - Article 47 of Regulation 2017/1001)
      (2019/C 432/48)
      Language of the case: English
      
         Parties
      
      
         Applicant: Intas Pharmaceuticals Ltd (Ahmedabad, India) (represented by: F. Traub, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: J. Crespo Carrillo and H. O’Neill, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Laboratorios Indas, SA (Pozuelo de Alarcón, Spain) (represented by: A. Gómez López, lawyer)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 16 April 2018 (Case R 815/2017-4), relating to opposition proceedings between Laboratorios Indas and Intas Pharmaceuticals.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Intas Pharmaceuticals Ltd to pay the costs.
                  
               
            
         (1)  OJ C 294, 20.8.2018.